JLE

Epileptic Disorders

MENU

Oxcarbazepine-induced myoclonic status epilepticus in juvenile myoclonic epilepsy Volume 15, issue 2, June 2013

Chapman K, Holland K, Erenberg G. Seizure exacerbation associated with oxcarbazepine in idiopathic focal epilepsy of childhood. Neurology 2003 ; 61 : 1012-1013.

Gelisse P, Genton P, Kuate C, et al. Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies. Epilepsia 2004 ; 45 : 1282-1286.

Genton P, Salas Puig X, Tunon A, Lahoz C, Del Socorro Gonzales A, Sanchez M. Juvenile myoclonic epilepsy and related syndromes: clinical and neurophysiological aspects. In: Malafosse A, Genton P, Hirsch E, Marescaux B, Broglin D, Bernasconi R. Idiopathic generalized epilepsies. London: John Libbey, 1994: 253-65.

Genton P, Gelisse P, Thomas P, Dravet C. Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy?. Neurology 2000 ; 55 : 1106-1109.

Grosso S, Balestri M, Di Bartolo RM, et al. Oxcarbazepine and atypical evolution of benign idiopathic focal epilepsy of childhood. Eur J Neurol 2006 ; 13 : 1142-1145.

Jayalakshmi SS, Srinivasa Rao B, Sailaja S. Focal clinical and electroencephalographic features in patients with juvenile myoclonic epilepsy. Acta Neurol Scand 2010 ; 122 : 115-123.

Kaddurah AK, Holmes G.L. Possible precipitation of myoclonic seizures with oxcarbazepine. Epilepsy Behav 2006 ; 8 : 289-293.

Liu L, Zheng T, Morris MJ, et al. The mechanism of carbamazepine aggravation of absence seizures. J Pharmacol Exp Ther 2006 ; 319 : 790-798.

Menon R, Baheti NN, Cherian A, Iyer R.S. Oxcarbazepine induced worsening of seizures in Jeavons syndrome: lessons learnt from an interesting presentation. Neurol India 2011 ; 59 : 70-72.

Osorio I, Reed RC, Peltzer J.N. Refractory idiopathic absence status epilepticus: a probable paradoxical effect of phenytoin and carbamazepine. Epilepsia 2000 ; 41 : 887-894.

Perucca E, Gram L, Avanzini G, et al. Antiepileptic drugs as a cause of worsening seizures. Epilepsia 1998 ; 39 : 5-17.

Rubboli G, Tassinari C.A. Negative myoclonus. An overview of its clinical features, pathophysiological mechanisms, and management. Neurophysiol Clin 2006 ; 36 : 337-343.

Thomas P, Valton L, Genton P. Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy. Brain 2006 ; 129 : 1281-1292.

Veerapandiyan A, Singh P, Mikati M.A. Possible induction of West syndrome by oxcarbazepine therapy in a patient with complex partial seizures. Epileptic Disord 2012 ; 14 : 99-10310.1684/epd.2012.0491.

Vendrame M, Khurana DS, Cruz M, et al. Aggravation of seizures and/or EEG features in children treated with oxcarbazepine monotherapy. Epilepsia 2007 ; 48 : 2116-2120.

Zheng T, Clarke AL, Morris MJ, Reid CA, Petrou S, O’Brien T.J. Oxcarbazepine, not its active metabolite, potentiates GABAA activation and aggravates absence seizures. Epilepsia 2009 ; 50 : 83-87.